ACTIVE

HuVePharma

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result5,9 M €+23,3 %over 1 year

Revenue127,1 M €+10,5 %over 1 year

Equity49,8 M €+13,4 %over 1 year

Workforce102,2 ETP+24,6 %over 1 year

Identity

Source · BCE/KBO

HuVePharma is a Public limited company incorporated in 2005. Its main activity is: Wholesale of grain, unmanufactured tobacco, seeds and animal feeds. Its registered office is in Antwerpen. It employs on average 102,2 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0875.283.062
Incorporation: 27/07/2005
Legal form: Public limited company
Registered office: Uitbreidingstraat 80
2600 Antwerpen · FlandreSee on map
Contributed capital: 4 500 000,00 €
Latest accounts: 31/12/2025
Average workforce: 102,2 ETP

Activities (NACE)

46216Wholesale of grain, unmanufactured tobacco, seeds and animal feeds· main 46216Wholesale of grain, unmanufactured tobacco, seeds and animal feeds 46389Wholesale of other food, including fish, crustaceans and molluscs 46389Wholesale of other food, including fish, crustaceans and molluscs 51210Freight air transport 51384Air transport

Joint committees (1)

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 32 filings

Trend over 18 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	127,1 M €	+10.5%	115 M €	+14.7%	100,3 M €	-0.4%	100,7 M €	+5.5%	95,5 M €
EBITDA	21,5 M €	+13.7%	18,9 M €	+6.1%	17,8 M €	+0.2%	17,8 M €	+1.9%	17,5 M €
Operating result	8,4 M €	+23.2%	6,8 M €	+8.7%	6,3 M €	-2.2%	6,4 M €	-1.4%	6,5 M €
Net result	5,9 M €	+23.3%	4,8 M €	+11.4%	4,3 M €	-1.2%	4,3 M €	-8.6%	4,8 M €
Balance sheet
Equity	49,8 M €	+13.4%	43,9 M €	+12.2%	39,1 M €	+12.3%	34,8 M €	+14.2%	30,5 M €
Total assets	107,7 M €	+10.4%	97,5 M €	+18.0%	82,7 M €	+1.9%	81,1 M €	+2.0%	79,5 M €
Cash	4,6 M €	-20.8%	5,8 M €	+33.1%	4,4 M €	-6.4%	4,7 M €	+19.7%	3,9 M €
Debts	50,5 M €	+4.8%	48,2 M €	+26.5%	38,1 M €	-7.7%	41,3 M €	-9.3%	45,6 M €
Other
Workforce	102,2 ETP	+24.6%	82,0 ETP	+1.2%	81,0 ETP	+2.1%	79,3 ETP	+4.2%	76,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
SDL Management1004.519.033Represented by Sven Verbraeken	Director16/05/2024 → 16/05/2030
Eddy PIRON	Managing director25/07/2005 → 17/05/2029
Kiril DOMUSCHIEV	Chairman of the board of directors25/07/2005 → 17/05/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Sven VERBRAEKEN	Director10/12/2014 → 2023 accounts
Kirirl DOMUSCHIEV	Chairman of the board of directors18/05/2017 → 2019 accounts

Other companies at this address

Uitbreidingstraat 80 2600 Antwerpen

Company	CBE no.
Multiservice FINANCE● Bankrupt	0879.561.554
TriFinance Belgium● Active	0882.734.939

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	19/06/2026	14/06/2025	24/06/2024	05/06/2023	21/06/2022	22/10/2021
General meeting	21/05/2026	15/05/2025	16/05/2024	19/05/2023	19/05/2022	28/09/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 32 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	21/05/2026	19/06/2026	Dutch	PDF
Full model	31/12/2024	15/05/2025	14/06/2025	Dutch	PDF
Consolidated accounts	31/12/2024	15/05/2025	14/06/2025	Dutch	PDF
Full model	31/12/2023	16/05/2024	24/06/2024	Dutch	PDF
Consolidated accounts	31/12/2023	16/05/2024	24/06/2024	Dutch	PDF
Full model	31/12/2022	19/05/2023	05/06/2023	Dutch	PDF
Consolidated accounts	31/12/2022	19/05/2023	05/06/2023	Dutch	PDF
Full model	31/12/2021	19/05/2022	21/06/2022	Dutch	PDF
Consolidated accounts	31/12/2021	19/05/2022	21/06/2022	Dutch	PDF
Full modelCorrection	31/12/2020	28/09/2021	22/10/2021	Dutch	PDF
Full model	31/12/2020	20/05/2021	28/05/2021	Dutch	PDF
Consolidated accounts	31/12/2020	20/05/2021	27/05/2021	Dutch	PDF
Full model	31/12/2019	21/05/2020	17/06/2020	Dutch	PDF
Consolidated accounts	31/12/2019	21/05/2020	17/06/2020	Dutch	PDF
Full model	31/12/2018	16/05/2019	23/06/2019	Dutch	PDF
Consolidated accounts	31/12/2018	16/05/2019	23/06/2019	Dutch	PDF
Full model	31/12/2017	17/05/2018	18/06/2018	Dutch	PDF
Consolidated accounts	31/12/2017	17/05/2018	18/06/2018	Dutch	PDF
Full model	31/12/2016	18/05/2017	28/06/2017	Dutch	PDF
Consolidated accounts	31/12/2016	18/05/2017	30/06/2017	Dutch	PDF
Full model	31/12/2015	19/05/2016	28/06/2016	Dutch	PDF
Consolidated accounts	31/12/2015	19/05/2016	22/07/2016	Dutch	PDF
Full model	31/12/2014	21/05/2015	29/06/2015	Dutch	PDF
Consolidated accounts	31/12/2014	21/05/2015	28/07/2015	Dutch	PDF

View all 32 filings

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
SDL Management1004.519.033Represented by Sven Verbraeken	Director16/05/2024 → 16/05/2030
Eddy PIRON	Managing director25/07/2005 → 17/05/2029
Kiril DOMUSCHIEV	Chairman of the board of directors25/07/2005 → 17/05/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Sven VERBRAEKEN	Director10/12/2014 → 2023 accounts
Kirirl DOMUSCHIEV	Chairman of the board of directors18/05/2017 → 2019 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates27/08/2026
Ontslag - (her)benoeming (gedelegeerd) bestuurder(s)
PDF
Mandates21/01/2025
ONTSLAGEN - BENOEMINGEN
PDF
Other07/12/2023
DIVERSEN
PDF
Mandates03/07/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/09/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/05/2021
ONTSLAGEN - BENOEMINGEN
PDF
Other06/12/2019
DIVERSEN
PDF
Mandates27/08/2018
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings18 filings

Mandates

SDL Management

Kiril DOMUSCHIEV

Eddy PIRON

Sven VERBRAEKEN

Kirirl DOMUSCHIEV

ASSIST MANAGEMENT

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027202820292030

HuVePharma

Uitbreidingstraat 80, 2600 Berchem (Antwerp)

Director

Chairman of the board of directors

Managing director

Director

Chairman of the board of directors

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Uitbreidingstraat 80, 2600 Berchem (Antwerp)Current	accounts 2021 → 2025	Accounts 2025 · 2026-00175321

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
HuVePharmaCurrent	accounts 2006 → 2025	Accounts 2025 · 2026-00175321

Events

2025
Annual accounts 20255,9 M €↑
2024
Annual accounts 20244,8 M €↑
16/05/2024
reconductionBDO Bedrijfsrevisoren · commissaris
16/05/2024
nominationDavid Lenaerts · vaste vertegenwoordiger
16/05/2024
nominationSDE Management · bestuurder
16/05/2024
nominationSven Verbraeken · vaste vertegenwoordiger
2023
Annual accounts 20234,3 M €↓
19/05/2023
reconductionKiril Domuschiev · bestuurder
19/05/2023
reconductionEddy Piron · bestuurder
2022
Annual accounts 20224,3 M €↓
2021
Annual accounts 20214,8 M €↑
2020
Annual accounts 20204,2 M €↑
2019
Annual accounts 20193,5 M €↑
2018
Annual accounts 20183,1 M €↑
2017
Annual accounts 20172,9 M €↑
2015
Annual accounts 20151,3 M €↓
2014
Annual accounts 20141,8 M €↑
2012
Annual accounts 2012922,7 k €↓
2011
Annual accounts 20111,1 M €↓
2010
Annual accounts 20101,3 M €↑
2009
Annual accounts 2009767,8 k €↑
2008
Annual accounts 200870,3 k €↑
2007
Annual accounts 2007-1,6 M €↑
2006
Annual accounts 2006-1,6 M €
27/07/2005
IncorporationPublic limited company

HuVePharma

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events